PubMed Health⌕ Search

PubMed · 3964648

Fluid-phase assembly of the membrane attack complex of complement.

Abstract

The dynamics and protein stoichiometry of the fluid-phase assembly of the membrane attack complex of complement were characterized by using light-scattering intensity measurements. The assembly proceeded in an ordered manner with generation of stable and highly reproducible intermediates. In the absence of phospholipid or C8, mixtures of C5b-6 and C7 self-associated to fluid phase-C5b-7 which had a weight-average molecular weight of (4.1 +/- 0.2) X 10(6). This corresponded to an average of nine C5b-7 complexes per particle. The particles appeared heterodisperse on sucrose gradients with S20,W values ranging from 21 to 39 S. Addition of C8 and C9 caused no further aggregation or disassembly of the particles. When excess C8 was added to the aggregated C5b-7, the ratio of C8 incorporated per C5b-7 moiety was 0.98 +/- 0.03. At saturating levels of C9, the C9/C5b-8 ratio in the particles was 7.2 +/- 0.6. Incorporation of C8 caused a small increase in the Z-averaged particle diffusion coefficient [(9.9-10.3) X 10(-8) cm2/s], indicating that it added in a manner that "filled in the gaps" in the C5b-7 particles. C9 caused only small decreases in the particle diffusion coefficient and substantially decreased the f/fmin ratio. The time course for C9 incorporation into fluid phase-C5b-8 indicated an initial rapid phase followed by a slow phase. The rapid phase corresponded to the incorporation of about one C9 for every two C5b-8 complexes. This suggested that one C9 binding site was accessible on about half of the C5b-8 complexes. This may imply that only about half of the C5b-8 complexes were capable of C9 polymerization so that the ratio of C9 incorporated per functional C5b-8 was (14 +/- 2)/1. The initial velocity of the slow phase of C9 addition gave an activation energy of 37 kcal/mol. The activation energy for C5b-8-independent polymerization of C9 had a similar value of 41 kcal/mol. Light-scattering intensity measurements seemed to be a highly reliable method for quantitative characterization of the fluid-phase assembly.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R E Silversmith, G L Nelsestuen. 1986-02-25. Fluid-phase assembly of the membrane attack complex of complement.. https://doi.org/10.1021/bi00352a016

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Complement C7 deficiency: seven further molecular defects and their associated marker haplotypes.

Seven further molecular bases of C7 deficiency are described. All these new molecular defects involve single-nucleotide events, deletions and substitutions, some of which alter splice sites, and others codons. They are distributed along the C7 gene, but predominantly towards the 3' end. All were found in compound heterozygous individuals. The C6/C7 marker haplotypes associated with most C7 defects are tabulated.

Complement C7↗

Complement component C7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7.

C7 M/N typing, the determination of the allotypes of the recently described C7 M/N protein polymorphism, was conducted on serum samples from donors and recipients of 100 liver transplantations to determine whether the liver is the predominant site of in vivo synthesis of human complement protein C7. Twenty-one cases were informative as the recipient was transplanted with the liver obtained from a donor with a different C7 M/N allotype. The determination of the C7 levels and phenotypes of up to 10 post-transplantation (p.t.) samples revealed that there was at most only a 50% contribution of the transplanted liver toward the C7 M/N allotype at 2 to 3 wk p.t.; that influence decreased with time and was approximately 10% in the samples obtained later than 6 wk after transplantation. C7 is thus the only terminal complement component not predominantly synthesized by hepatocytes, which is compatible with the observation that C7 is not an acute phase reactant. The transient contribution of the donor phenotype appears to be attributable to cells of the mononuclear phagocyte lineage, Kupffer cells in particular that are replaced by cells of recipient origin. Various cells of that lineage that are known to synthesize C7 in vitro, therefore, contribute more toward the C7 concentration than previously anticipated. Enhanced local C7 synthesis at the site of inflammation might add further to the basic C7 level especially because C7 is often the limiting factor for terminal complement complex generation.

Complement C7↗